EP 1066054 A2 20010110 - USE OF ACTIVE P40 CONJUGATES FOR NASAL DELIVERY
Title (en)
USE OF ACTIVE P40 CONJUGATES FOR NASAL DELIVERY
Title (de)
VERWENDUNG VON WIRKSAMEN P40 KONJUGIERTEN ZUR NASALE VERABREICHUNG
Title (fr)
UTILISATION DE CONJUGUES P40 ACTIFS PAR VOIE NASALE
Publication
Application
Priority
- FR 9900703 W 19990326
- FR 9803814 A 19980327
Abstract (en)
[origin: FR2776521A1] The invention concerns the use of at least an enterobacteria outer membrane protein A fragment or a Klebsiella membrane protein fragment for preparing a pharmaceutical composition for nasal delivery, to improve a mammal's immunity to an antigen or a hapten.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 38/00 (2006.01); A61K 39/09 (2006.01); A61K 39/095 (2006.01); A61K 39/12 (2006.01); A61K 39/145 (2006.01); A61K 39/155 (2006.01); A61K 39/385 (2006.01); A61K 39/39 (2006.01); A61K 47/48 (2006.01); A61P 37/02 (2006.01); A61P 37/04 (2006.01); C07K 14/26 (2006.01); C07K 19/00 (2006.01); C12N 15/09 (2006.01)
CPC (source: EP)
A61K 39/385 (2013.01); A61P 37/02 (2017.12); A61P 37/04 (2017.12); A61K 2039/543 (2013.01); A61K 2039/6068 (2013.01)
Citation (search report)
See references of WO 9949892A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
FR 2776521 A1 19991001; FR 2776521 B1 20001215; AU 2939199 A 19991018; AU 764061 B2 20030807; BR 9909180 A 20001205; CA 2324477 A1 19991007; CN 1243569 C 20060301; CN 1301176 A 20010627; EP 1066054 A2 20010110; JP 2002509897 A 20020402; WO 9949892 A2 19991007; WO 9949892 A3 20000330
DOCDB simple family (application)
FR 9803814 A 19980327; AU 2939199 A 19990326; BR 9909180 A 19990326; CA 2324477 A 19990326; CN 99806265 A 19990326; EP 99910434 A 19990326; FR 9900703 W 19990326; JP 2000540854 A 19990326